Trifluoroacetic acid → [6-Chloro-5-(1-isopropyl-piperidin-4-yloxy)-1H-indol-2-yl]-piperazin-1-yl-methanone
反応式
C(OC([N:8]1[CH2:13][CH2:12][N:11]([C:14]([C:16]2[NH:17][C:18]3[C:23]([CH:24]=2)=[CH:22][C:21]([O:25][CH:26]2[CH2:31][CH2:30][N:29]([CH:32]([CH3:34])[CH3:33])[CH2:28][CH2:27]2)=[C:20]([Cl:35])[CH:19]=3)=[O:15])[CH2:10][CH2:9]1)=O)(C)(C)C.FC(F)(F)C(O)=O>ClCCl>[Cl:35][C:20]1[CH:19]=[C:18]2[C:23]([CH:24]=[C:16]([C:14]([N:11]3[CH2:12][CH2:13][NH:8][CH2:9][CH2:10]3)=[O:15])[NH:17]2)=[CH:22][C:21]=1[O:25][CH:26]1[CH2:27][CH2:28][N:29]([CH:32]([CH3:34])[CH3:33])[CH2:30][CH2:31]1参加物
反応物 2
生成物 1
試薬・触媒・溶媒 1
実験手順
To a cold (0° C.) solution of 4-[6-chloro-5-(1-isopropyl-piperidin-4-yloxy)-1H-indole-2-carbonyl]-piperazine-1-carboxylic acid tert-butyl ester (example 3, 547 mg, 1.0 eq.) in dichloromethane was added trifluoroacetic acid (1.23 mL, 10 eq.) dropwise. The reaction mixture was stirred 3 h at room temperature. The mixture was concentrated in vacuo and the residue was partitioned between ethyl acetate and a saturated aqueous sodium carbonate solution. The aqueous phase was extracted with ethyl acetate and the combined organic phases were dried over sodium sulfate, filtered and the solvents removed in vacuo. The residue was purified by flash chromatography on silica gel with a 90:9:1 dichloromethane/methanol/ammonia eluant to afford 413 mg (94%) of the title compound as a light-yellow solid.
後処理
- concentrationThe mixture was concentrated in vacuo
- customthe residue was partitioned between ethyl acetate
- extractionThe aqueous phase was extracted with ethyl acetate
- dry with materialthe combined organic phases were dried over sodium sulfate
- filtrationfiltered
- customthe solvents removed in vacuo
- customThe residue was purified by flash chromatography on silica gel with a 90:9:1 dichloromethane/methanol/ammonia eluant
出典と根拠
- ORDレコード
- ord-04b9f57d0cd4482a9aa02d8215ee1801
- 出典データセット
- uspto-grants-2009_03
- 特許番号
- US07507736B2
反応ノート
読み込み中…